Swiss Personal Products Stock News

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

With its stock down 20% over the past three months, it is easy to disregard Ypsomed Holding (VTX:YPSN). But if you pay...

Those following along with Amrize AG ( VTX:AMRZ ) will no doubt be intrigued by the recent purchase of shares by Jan...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Chocoladefabriken Lindt & Sprüngli fair value estimate is...

Key Insights Significant control over Vetropack Holding by retail investors implies that the general public has more...

Key Insights Bystronic's estimated fair value is CHF299 based on 2 Stage Free Cash Flow to Equity Current share price...

Bell Food Group (VTX:BELL) has had a rough three months with its share price down 11%. However, stock prices are...

Shares of Nestlé (SWX:NESN) have attracted renewed interest lately, as investors dig deeper into how the company’s fundamentals measure up. The recent price movements provide an opportunity to reassess where things stand for the Swiss food giant. See our latest analysis for Nestlé. While Nestlé shares recently pulled back, giving up ground over the past week, the stock has actually gained some positive momentum in the last month and quarter. Despite this, its 1-year total shareholder return...

ALSO Holding AG ( VTX:ALSN ), might not be a large cap stock, but it saw significant share price movement during recent...

DKSH Holding's (VTX:DKSH) stock up by 3.3% over the past month. As most would know, long-term fundamentals have a...

Smartee Denti-Technology and Straumann Group recently announced a partnership to jointly develop next-generation orthodontics platforms, co-innovate clear aligner technologies, and involve a single-digit equity investment by Smartee. This collaboration combines Smartee's manufacturing and technology expertise in China's clear aligner market with Straumann's global brand and distribution network, aiming to meet rising global demand for high-quality orthodontic solutions more...

Amrize AG in late October reported third quarter 2025 results showing US$3.68 billion in sales and raised its full-year 2025 revenue guidance to between US$11.7 billion and US$12.0 billion. The company also signaled a continued appetite for mergers and acquisitions, with leadership emphasizing a robust pipeline of potential deals alongside increased investment in organic growth. With a reinforced revenue outlook and active acquisition plans, we’ll explore how Amrize’s growth ambitions shape...

Earlier this month, the Canadian Space Agency awarded ABB a contract to develop the conceptual design of the Thin Ice Clouds and Far InfraRed Emissions (TICFIRE) instrument, a critical part of Canada's High-altitude Aerosols, Water Vapour and Clouds (HAWC) satellite mission for climate monitoring. This initiative highlights the importance of advanced infrared sensing technologies in addressing pressing climate science questions that traditional observation methods cannot resolve from Earth’s...

When you buy a stock there is always a possibility that it could drop 100%. But on the bright side, if you buy shares...

As European markets experience a notable upswing, with the STOXX Europe 600 Index and major stock indexes like Germany’s DAX and the UK’s FTSE 100 showing strong gains, investors are increasingly interested in identifying stocks that may be trading below their intrinsic value. In this environment of rising business activity and improving consumer confidence, finding undervalued stocks can offer potential opportunities for those looking to capitalize on market inefficiencies.

Luzerner Kantonalbank AG announced earnings results for the nine months ended September 30, 2025, posting net interest income of CHF 353.17 million and net income of CHF 223.34 million, both higher than the same period last year. This steady rise in both key profit and revenue measures underscores the bank's consistent financial performance over the ongoing period. We'll examine how robust growth in net interest income shapes Luzerner Kantonalbank's investment narrative going...

Galderma Group AG recently raised its full-year 2025 net sales growth guidance to 17.0-17.7% at constant currency, reflecting especially strong contributions from Nemluvio and Injectable Aesthetics segments. This guidance increase underscores the momentum in Therapeutic Dermatology and the company's ongoing ability to outperform the broader aesthetics market with its key innovations. We'll examine how this raised guidance, particularly from the rapid ramp-up of Nemluvio, could influence...

UBS Group (SWX:UBSG) reported net profit margins of 15.2%, a leap from 8.5% a year ago, and posted 81.8% earnings growth over the past year, substantially higher than its five-year average growth of 6.8% per year. Investors are weighing these strong results and an earnings growth forecast of 17.8% per year, which outpaces the Swiss market's 10.6% expectation, against the reality of a large, non-recurring $4.2 billion loss that affected recent results and ongoing concerns about dividend...

RiPSIM Technologies recently announced that Swisscom Ventures, the venture capital arm of Swisscom AG, led a strategic investment round to accelerate the growth of RiPSIM's eSIM-as-a-Service management platform. This move is expected to modernize the way eSIMs are generated and delivered, potentially broadening Swisscom's enterprise reach in the evolving telecommunications landscape. With Swisscom Ventures supporting the expansion of eSIM services for enterprise clients, we'll explore the...

Amrize (SWX:AMRZ) reported its net profit margin at 10%, edging higher than last year’s 9.5%, a clear sign of better profitability. Over the past five years, the company’s earnings have grown at an annual rate of 8.1%, but the latest twelve months saw a slower 4.9% rise. With analysts forecasting earnings growth of 15.4% per year, comfortably ahead of both the Swiss market and industry peers, investors are now weighing the implications of robust growth expectations against a share price that...

Novartis (SWX:NOVN) posted strong earnings for the period, with profits rising 22.4% year over year, well above its 5-year average annual growth of just 0.09%. Net profit margin climbed to 25.5% from 23.6% a year ago, signaling improved profitability. While revenue growth is forecast at 3.4% per year, trailing the Swiss market average of 4%, ongoing momentum and a current share price of CHF98.5, which is below estimated fair value, give investors plenty to analyze as they look ahead. See our...

Harrington Process Solutions recently announced an expansion of its partnership with Georg Fischer, granting Harrington full-line access to Georg Fischer's flow control products for corrosive waste and high purity applications across the United States. This expanded collaboration strengthens both companies' capabilities and market reach, particularly in mission-critical industries such as data centers, life sciences, and biopharmaceuticals. We'll examine how broader national distribution of...

Sandoz Group AG recently presented at CPhI Worldwide Frankfurt 2025, highlighting new developments with key presentations from its Chief Commercial Officer and Chief Scientific Officer at Messe Frankfurt in Germany. For the first nine months of 2025, Sandoz reported a 5% net sales increase at constant currencies, with biosimilars making up over 30% of total net sales for the first time and an upgraded full-year margin outlook reflecting successful infrastructure expansion. We will consider...